MedTrace Logo

Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout

NCT06887452 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 310

Last updated 2026-02-19

No results posted yet for this study

Summary

This study will compare two different approaches to manage medications that lower uric acid levels. This study will be conducted at five VA medical centers across the United States and will take 4-5 years to complete. Individual participation will last up to two years.

Conditions

  • Gout
  • Gouty Arthritis

Interventions

OTHER

Pharmacist-Led

Pharmacist will conduct regular telehealth visits with Veterans during dose escalation phase of gout treatment

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Ted R. Mikuls · Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-01
Primary Completion
2029-10-01
Completion
2031-03-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06887452 on ClinicalTrials.gov